Welcome!

News Feed Item

Molecular Biology Enzymes, Kits, & Reagents Market by Application (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing), Product (Ligase, Phosphatase, Polymerase, Protease, Restriction Endonuclease, Reverse Transcriptase)-Global Forecast to 2018

NEW YORK, Aug. 25, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Molecular Biology Enzymes, Kits, & Reagents Market by Application (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing), Product (Ligase, Phosphatase, Polymerase, Protease, Restriction Endonuclease, Reverse Transcriptase)-Global Forecast to 2018

http://www.reportlinker.com/p02316118/Molecular-Biology-Enzymes-Kits--Reagents-Market-by-Application-Cloning-Epigenetics-PCR-Restriction-Digestion-Sequencing-Product-Ligase-Phosphatase-Polymerase-Protease-Restriction-Endonuclease-Reverse-Transcriptase-Global-Forecast-to-2018.html

The global molecular biology enzymes, kits and reagents market is segmented by application, end users, products, and geographies. Molecular biology enzymes, kits and reagents find applications in a large number of fields of life science research. The application segments included in this report are cloning, epigenetics, PCR (polymerase chain reaction), restriction digestion, sequencing, and other applications. The end-user segments of this market are academic research institutes, hospitals and diagnostics centers, pharmaceutical and biotech companies, and other end users.

The product segments included in this report are enzymes, and kits & reagents. The enzymes segment is divided into the ligases, phosphatases, polymerases, proteases and proteinases, restriction endonucleases, reverse transcriptases, and other enzymes sub-segments. The ligase enzyme sub-segment is further divided into T4 DNA ligase, thermostable DNA ligase, and other ligases. The polymerase enzyme sub-segment is divided into high fidelity DNA polymerase, T4 DNA polymerase, Taq DNA polymerase, and other polymerases, while the restriction endonuclease enzyme sub-segment is divided into BamHI, EcoRI, PstI, and other restriction endonucleases.

The kits and reagents product segment has five sub-segments, namely, cloning and mutagenesis, nucleic acid analysis, PCR sequencing, and other kits and reagents.

The geographic segments included in this report are Asia, Europe, North America and Rest of the World (RoW). Asia is further divided into the regional segments of China, India, Japan, and Rest of Asia. Europe is divided into the regional segments of France, Germany, Italy, Spain, the U.K., and the Rest of Europe. North America includes Canada, and U.S. RoW encompasses Latin America, Middle East and Africa, and the Pacific countries.

The key drivers for this market are the rising R&D expenditure by the pharmaceutical and biotech companies, and increasing public funding for life science research. The World Health Organization estimates that the total aged population may rise from 605 million in 2000 (11% of the global population) to 2 billion by 2050, accounting for 22% of the global population. As this segment of the world population is more susceptible to chronic diseases, research into these ailments will become more significant, driving the growth of the molecular biology enzymes, kits & reagents market.

A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global molecular biology enzymes, kits and reagents market and its sub-segments. Secondary information was used to identify overall revenue, geographic reach, and product portfolios of market players. Estimates of their molecular biology enzymes, kits and reagents market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each sub-segment and the relative differences in growth rates.

The report provides qualitative insights on key market shares, growth rates, and market drivers for all important sub-segments. It maps market sizes and growth rates of each sub-segment and identifies the segments poised to see rapid growth. The report also includes company profiles of market leaders. These company profiles include the financial performances, product portfolios, and developments of each company. The report also provides a competitive landscape of the molecular biology enzymes, kits and reagents market. The competitive landscape covers the growth strategies adopted by industry players over the last three years. It also includes analyses of industry developments like mergers and acquisitions, agreements and partnerships, and new product launches.

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.

The report provides insights on the following:
- Product Development/Innovation: Product portfolios of top players in the molecular biology enzymes, kits and reagents market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the molecular biology enzymes, kits and reagents market
- Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of leading players in the molecular biology enzymes, kits and reagents market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various molecular biology enzymes, kits and reagents products across geographies
- Market Diversification: Exhaustive information about new products and services, recent developments, and investments in the molecular biology enzymes, kits and reagents market
TABLE OF CONTENTS

1 INTRODUCTION 21
1.1 OBJECTIVES OF THE STUDY 21
1.2 MARKETS COVERED 22
1.3 STAKEHOLDERS 24
1.4 RESEARCH METHODOLOGY 25
1.4.1 SECONDARY RESEARCH 25
1.4.1.1 Key data from secondary sources 26
1.4.2 PRIMARY RESEARCH 27
1.4.2.1 Key data from primary sources 27
1.4.3 MARKET SIZE ESTIMATION METHODOLOGY 28
1.4.4 MARKET FORECAST 29
1.4.5 MARKET DATA VALIDATION AND DATA TRIANGULATION 30
1.5 ASSUMPTIONS 31
2 EXECUTIVE SUMMARY 32
3 MARKET OVERVIEW 37
3.1 INTRODUCTION 38
3.2 MARKET SEGMENTATION 38
3.3 MARKET DYNAMICS 40
3.3.1 MARKET DRIVERS 41
3.3.1.1 Increased funding in life science research to propel the growth of the molecular biology enzymes and kits & reagents market 41
3.3.1.2 Increased intensity of research activities in the pharmaceutical sector to drive the market 41
3.3.1.3 Growth in genomics and molecular diagnostics markets will aid the growth of the molecular biology enzymes and kits & reagents market 42
3.3.1.4 Increased healthcare spending will aid the growth of the molecular biology enzymes and kits & reagents market 42
3.3.1.5 Rapidly aging population and chronic and infectious diseases are expected to drive the molecular biology enzymes and kits & reagents market 43
3.3.2 MARKET RESTRAINTS 43
3.3.2.1 Stringent regulatory framework acts as a major challenge 43
3.3.2.2 High degree of consolidation would act as a high entry barrier for new entrants 44
3.3.3 MARKET OPPORTUNITIES 44
3.3.3.1 Increased use of personalized medicine 44
3.3.3.2 Developing countries present significant opportunities for the molecular biology enzymes and kits & reagents market 44
3.4 MARKET SHARE ANALYSIS 45
4 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY APPLICATION 48
4.1 INTRODUCTION 49
4.2 CLONING 52
4.3 EPIGENETICS 54
4.4 PCR 55
4.5 RESTRICTION DIGESTION 57
4.6 SEQUENCING 58
4.7 OTHER APPLICATIONS 60
5 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY END USER 62
5.1 INTRODUCTION 63
5.2 ACADEMIC RESEARCH INSTITUTES 66
5.3 HOSPITALS AND DIAGNOSTICS CENTERS 68
5.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 69
5.5 OTHER END USERS 71
6 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY PRODUCT 73
6.1 INTRODUCTION 74
6.2 ENZYMES 76
6.2.1 LIGASES 81
6.2.2 PHOSPHATASES 82
6.2.3 POLYMERASES 83
6.2.4 PROTEASES AND PROTEINASES 86
6.2.5 RESTRICTION ENDONUCLEASES 87
6.2.6 REVERSE TRANSCRIPTASES 89
6.2.7 OTHER ENZYMES 91
6.3 KITS & REAGENTS 92
6.3.1 CLONING AND MUTAGENESIS 96
6.3.2 NUCLEIC ACID ANALYSIS 98
6.3.3 PCR 99
6.3.4 SEQUENCING 101
6.3.5 OTHER KITS AND REAGENTS 102
7 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY GEOGRAPHY 104
7.1 INTRODUCTION 105
7.2 ASIA 108
7.2.1 CHINA 118
7.2.2 INDIA 125
7.2.3 JAPAN 131
7.2.4 REST OF ASIA (ROA) 138
7.3 EUROPE 145
7.3.1 FRANCE 154
7.3.2 GERMANY 160
7.3.3 ITALY 166
7.3.4 SPAIN 172
7.3.5 U.K. 179
7.3.6 REST OF EUROPE (ROE) 185
7.4 NORTH AMERICA 191
7.4.1 CANADA 200
7.4.2 U.S. 206
7.5 REST OF THE WORLD (ROW) 213
7.5.1 LATIN AMERICA 221
7.5.2 MIDDLE EAST AND AFRICA 227
7.5.3 PACIFIC 234
8 COMPETITIVE LANDSCAPE 240
8.1 INTRODUCTION 240
8.2 NEW PRODUCT LAUNCHES 241
8.3 AGREEMENTS, COLLABORATIONS, PARTNERSHIPS, AND JOINT VENTURES 247
8.4 EXPANSIONS 253
8.5 MERGERS AND ACQUISITIONS 255
8.6 OTHER DEVELOPMENTS 256
9 COMPANY PROFILES 259
9.1 AFFYMETRIX, INC. 259
9.2 AGILENT TECHNOLOGIES, INC. 266
9.3 ENZYMATICS, INC. 270
9.4 ILLUMINA, INC. 273
9.5 NEW ENGLAND BIOLABS, INC. 280
9.6 QIAGEN, N.V. 287
9.7 ROCHE, LTD. 291
9.8 SIGMA-ALDRICH CORPORATION 294
9.9 TAKARA BIO, INC. 298
9.10 THERMO FISHER SCIENTIFIC, INC. 303

*Details on Business Overview, Company Snapshot, Product Portfolio, Key Strategy, & Recent Developments might not be captured in case of unlisted companies.

LIST OF TABLES

TABLE 1 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 52
TABLE 2 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE FOR CLONING, BY GEOGRAPHY, 2011–2018 ($MILLION) 53
TABLE 3 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE FOR EPIGENETICS, BY GEOGRAPHY,
2011–2018 ($MILLION) 55
TABLE 4 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE FOR PCR, BY GEOGRAPHY, 2011–2018 ($MILLION) 56
TABLE 5 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE FOR RESTRICTION DIGESTION, BY GEOGRAPHY,
2011–2018 ($MILLION) 58
TABLE 6 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE FOR SEQUENCING, BY GEOGRAPHY,
2011–2018 ($MILLION) 59
TABLE 7 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE FOR OTHER APPLICATIONS, BY GEOGRAPHY,
2011–2018 ($MILLION) 61
TABLE 8 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 66
TABLE 9 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY GEOGRAPHY, 2011–2018 ($MILLION) 67
TABLE 10 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE FOR HOSPITALS AND DIAGNOSTIC CENTERS,
BY GEOGRAPHY, 2011–2018 ($MILLION) 68
TABLE 11 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2011–2018 ($MILLION) 70
TABLE 12 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE FOR OTHER END USERS, BY GEOGRAPHY,
2011–2018 ($MILLION) 71
TABLE 13 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 75
TABLE 14 GLOBAL MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 79
TABLE 15 GLOBAL MOLECULAR BIOLOGY ENZYMES MARKET SIZE,
BY GEOGRAPHY, 2011–2018 ($MILLION) 80
TABLE 16 GLOBAL MOLECULAR BIOLOGY ENZYMES MARKET SIZE FOR LIGASES, BY GEOGRAPHY, 2011–2018 ($MILLION) 82
TABLE 17 GLOBAL MOLECULAR BIOLOGY ENZYMES MARKET SIZE FOR PHOSPHATASES, BY GEOGRAPHY, 2011–2018 ($MILLION) 83
TABLE 18 REPRESENTATIVE LIST FOR POLYMERASES PRODUCTS 84
TABLE 19 GLOBAL MOLECULAR BIOLOGY ENZYMES MARKET SIZE FOR POLYMERASES, BY GEOGRAPHY, 2011–2018 ($MILLION) 85
TABLE 20 GLOBAL MOLECULAR BIOLOGY ENZYMES MARKET SIZE FOR PROTEASES AND PROTEINASES, BY GEOGRAPHY,
2011–2018 ($MILLION) 87
TABLE 21 RESTRICTION ENDONUCLEASES ENZYME: RECONGNITION SEQUENCE AND MAJOR SUPPLIERS 88
TABLE 22 GLOBAL MOLECULAR BIOLOGY ENZYMES MARKET FOR RESTRICTION ENDONUCLEASES, BY GEOGRAPHY, 2011–2018 ($MILLION) 89
TABLE 23 GLOBAL MOLECULAR BIOLOGY ENZYMES MARKET SIZE FOR REVERSE TRANSCRIPTASES, BY GEOGRAPHY, 2011–2018 ($MILLION) 90
TABLE 24 GLOBAL MOLECULAR BIOLOGY ENZYMES MARKET SIZE FOR OTHER ENZYMES, BY GEOGRAPHY, 2011–2018 ($MILLION) 91
TABLE 25 GLOBAL MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 95
TABLE 26 GLOBAL MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE,
BY GEOGRAPHY, 2011–2018 ($MILLION) 96
TABLE 27 GLOBAL MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE FOR CLONING AND MUTAGENESIS, BY GEOGRAPHY, 2011–2018 ($MILLION) 97
TABLE 28 GLOBAL MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE FOR NUCLEIC ACID ANALYSIS, BY GEOGRAPHY, 2011–2018 ($MILLION) 99
TABLE 29 GLOBAL MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE FOR PCR, BY GEOGRAPHY, 2011–2018 ($MILLION) 100
TABLE 30 GLOBAL MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE FOR SEQUENCING, BY GEOGRAPHY, 2011–2018 ($MILLION) 102
TABLE 31 GLOBAL OTHER MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE, BY GEOGRAPHY, 2011–2018 ($MILLION) 103
TABLE 32 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY GEOGRAPHY, 2011–2018 ($MILLION) 107
TABLE 33 ASIA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY GEOGRAPHY, 2011–2018 ($MILLION) 112
TABLE 34 ASIA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 113
TABLE 35 ASIA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 114
TABLE 36 ASIA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 115
TABLE 37 ASIA: MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 116
TABLE 38 ASIA: MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 117
TABLE 39 CHINA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 120
TABLE 40 CHINA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 121
TABLE 41 CHINA: MOLECULAR BIOLOGY ENZYMES AND KITS, & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 122
TABLE 42 CHINA: MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 122
TABLE 43 CHINA: MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 124
TABLE 44 INDIA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 126
TABLE 45 INDIA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 127
TABLE 46 INDIA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 128
TABLE 47 INDIA: MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 128
TABLE 48 INDIA: MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 130
TABLE 49 JAPAN: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 133
TABLE 50 JAPAN: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 134
TABLE 51 JAPAN: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 135
TABLE 52 JAPAN: MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 135
TABLE 53 JAPAN: MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 137
TABLE 54 ROA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 140
TABLE 55 ROA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 141
TABLE 56 ROA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 142
TABLE 57 ROA: MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 142
TABLE 58 ROA: MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 144
TABLE 59 EUROPE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY GEOGRAPHY, 2011–2018 ($MILLION) 148
TABLE 60 EUROPE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 149
TABLE 61 EUROPE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 150
TABLE 62 EUROPE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 151
TABLE 63 EUROPE: MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 151
TABLE 64 EUROPE: MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 153
TABLE 65 FRANCE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 155
TABLE 66 FRANCE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 156
TABLE 67 FRANCE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 157
TABLE 68 FRANCE: MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 157
TABLE 69 FRANCE: MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 159
TABLE 70 GERMANY: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 161
TABLE 71 GERMANY: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 162
TABLE 72 GERMANY: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 163
TABLE 73 GERMANY: MOLECULAR BIOLOGY ENZYMES MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 163
TABLE 74 GERMANY: MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 165
TABLE 75 ITALY: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 167
TABLE 76 ITALY: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 168
TABLE 77 ITALY: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 169
TABLE 78 ITALY: MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 169
TABLE 79 ITALY: MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 171
TABLE 80 SPAIN: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 174
TABLE 81 SPAIN: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 175
TABLE 82 SPAIN: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 176
TABLE 83 SPAIN: MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 177
TABLE 84 SPAIN: MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 178
TABLE 85 U.K.: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 180
TABLE 86 U.K.: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 181
TABLE 87 U.K.: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 182
TABLE 88 U.K.: MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 182
TABLE 89 U.K.: MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 184
TABLE 90 ROE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 186
TABLE 91 ROE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 187
TABLE 92 ROE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 188
TABLE 93 ROE: MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 188
TABLE 94 ROE: MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 190
TABLE 95 NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY REGION, 2011–2018 ($MILLION) 194
TABLE 96 NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 195
TABLE 97 NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 196
TABLE 98 NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 197
TABLE 99 NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 197
TABLE 100 NORTH AMERICA: MOLECULAR BIOLOGY KITS AND REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 199
TABLE 101 CANADA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 201
TABLE 102 CANADA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 202
TABLE 103 CANADA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 203
TABLE 104 CANADA: MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 203
TABLE 105 CANADA: MOLECULAR BIOLOGY KITS AND REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 205
TABLE 106 U.S.: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 208
TABLE 107 U.S.: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 209
TABLE 108 U.S.: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 210
TABLE 109 U.S.: MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 210
TABLE 110 U.S.: MOLECULAR BIOLOGY KITS AND REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 212
TABLE 111 ROW: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY REGION, 2011–2018 ($MILLION) 216
TABLE 112 ROW: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 217
TABLE 113 ROW: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 218
TABLE 114 ROW: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 219
TABLE 115 ROW: MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 219
TABLE 116 ROW: MOLECULAR BIOLOGY KITS AND REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 221
TABLE 117 LATIN AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 223
TABLE 118 LATIN AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 224
TABLE 119 LATIN AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 225
TABLE 120 LATIN AMERICA: MOLECULAR BIOLOGY ENZYMES MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 225
TABLE 121 LATIN AMERICA: MOLECULAR BIOLOGY KITS AND REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 227
TABLE 122 MIDDLE EAST AND AFRICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 229
TABLE 123 MIDDLE EAST AND AFRICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 230
TABLE 124 MIDDLE EAST AND AFRICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 231
TABLE 125 MIDDLE EAST AND AFRICA: MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 231
TABLE 126 MIDDLE EAST AND AFRICA: MOLECULAR BIOLOGY KITS AND REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 233
TABLE 127 PACIFIC: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 235
TABLE 128 PACIFIC: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 236
TABLE 129 PACIFIC: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 237
TABLE 130 PACIFIC: MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 237
TABLE 131 PACIFIC: MOLECULAR BIOLOGY KITS AND REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 239
TABLE 132 NEW PRODUCT LAUNCHES, 2011–2014 241
TABLE 133 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND
JOINT VENTURES, 2011–2014 248
TABLE 134 EXPANSIONS, 2011–2014 253
TABLE 135 MERGERS AND ACQUISITIONS, 2011–2014 255
TABLE 136 OTHER DEVELOPMENTS, 2011–2014 257
LIST OF FIGURES

FIGURE 1 RESEARCH METHODOLOGY 25
FIGURE 2 MARKET SIZE ESTIMATION METHODOLOGY 28
FIGURE 3 MARKET FORECASTING MODEL 29
FIGURE 4 DATA TRIANGULATION METHODOLOGY 30
FIGURE 1 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2013 VS. 2018 ($MILLION) 32
FIGURE 2 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2013 VS. 2018 ($MILLION) 33
FIGURE 3 GLOBAL MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2013 VS. 2018 ($MILLION) 34
FIGURE 4 GLOBAL MOLECULAR BIOLOGY KITS AND REAGENTS MARKET SIZE,
BY PRODUCT, 2013 VS. 2018 ($MILLION) 35
FIGURE 5 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY GEOGRAPHY, 2013 VS. 2018 ($MILLION) 36
FIGURE 6 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SEGMENTATION 39
FIGURE 7 MARKET DRIVERS AND RESTRAINTS 40
FIGURE 8 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2013 46
FIGURE 9 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SEGMENTATION, BY APPLICATION 49
FIGURE 10 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY APPLICATION, 2013 (MARKET SIZE AND GROWTH RATE) 50
FIGURE 11 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2013 VS. 2018 ($MILLION) 51
FIGURE 12 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SEGMENTATION, BY END USER 63
FIGURE 13 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2013 (MARKET SIZE AND GROWTH RATES) 64
FIGURE 14 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2013 VS. 2018 ($MILLION) 65
FIGURE 15 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SEGMENTATION, BY PRODUCT 75
FIGURE 16 GLOBAL MOLECULAR BIOLOGY ENZYMES MARKET, BY PRODUCT,
2013 (MARKET SIZE AND GROWTH RATE) 77
FIGURE 17 GLOBAL MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2013 VS. 2018 ($MILLION) 78
FIGURE 18 GLOBAL MOLECULAR BIOLOGY KITS & REAGENTS MARKET,
BY PRODUCT, 2013 (MARKET SIZE AND GROWTH RATE) 93
FIGURE 19 GLOBAL MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE,
BY PRODUCT, 2013 VS. 2018 ($MILLION) 94
FIGURE 20 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY GEOGRAPHY, 2013 (MARKET SIZE AND GROWTH RATE) 105
FIGURE 21 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY GEOGRAPHY, 2013 VS. 2018 ($MILLION) 106
FIGURE 22 ASIA: ECONOMIC INDICATORS (2003–2012) 108
FIGURE 23 ASIA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY GEOGRAPHY, 2013 (MARKET SIZE AND GROWTH RATE) 110
FIGURE 24 ASIA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY GEOGRAPHY, 2013 VS. 2018 ($MILLION) 111
FIGURE 25 CHINA: ECONOMIC INDICATORS (2003–2012) 118
FIGURE 26 INDIA: ECONOMIC INDICATORS (2003–2012) 125
FIGURE 27 JAPAN: ECONOMIC INDICATORS (2003–2012) 131
FIGURE 28 ROA: ECONOMIC INDICATORS (2003–2012) 138
FIGURE 29 EUROPE: ECONOMIC INDICATORS (2003–2012) 145
FIGURE 30 EUROPE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY GEOGRAPHY, 2013 (MARKET SIZE AND GROWTH RATE) 146
FIGURE 31 EUROPE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY GEOGRAPHY, 2013 VS. 2018 ($MILLION) 147
FIGURE 32 FRANCE: ECONOMIC INDICATORS (2003–2012) 154
FIGURE 33 GERMANY: ECONOMIC INDICATORS (2003–2012) 160
FIGURE 34 ITALY: ECONOMIC INDICATORS (2003–2012) 166
FIGURE 35 SPAIN: ECONOMIC INDICATORS (2003–2012) 172
FIGURE 36 U.K.: ECONOMIC INDICATORS (2003–2012) 179
FIGURE 37 ROE: ECONOMIC INDICATORS (2003–2012) 185
FIGURE 38 NORTH AMERICA: ECONOMIC INDICATORS (2003–2012) 191
FIGURE 39 NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY REGION, 2013 (MARKET SIZE AND GROWTH RATE) 192
FIGURE 40 NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY REGION, 2013 VS. 2018 ($MILLION) 193
FIGURE 41 CANADA: ECONOMIC INDICATORS (2003–2012) 200
FIGURE 42 U.S.: ECONOMIC INDICATORS (2003–2012) 206
FIGURE 43 ROW: ECONOMIC INDICATORS (2003–2012) 213
FIGURE 44 ROW: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY REGION, 2013 (MARKET SIZE AND GROWTH RATE) 214
FIGURE 45 ROW: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY REGION, 2013 VS. 2018 ($MILLION) 215
FIGURE 46 LATIN AMERICA: ECONOMIC INDICATORS (2003–2012) 222
FIGURE 47 MIDDLE EAST AND AFRICA: ECONOMIC INDICATORS (2003–2012) 228
FIGURE 48 PACIFIC: ECONOMIC INDICATORS (2003–2012) 234
FIGURE 49 KEY GROWTH STRATEGIES FOR THE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, 2011–2014 240


To order this report: Molecular Biology Enzymes, Kits, & Reagents Market by Application (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing), Product (Ligase, Phosphatase, Polymerase, Protease, Restriction Endonuclease, Reverse Transcriptase)-Global Forecast to 2018
http://www.reportlinker.com/p02316118/Molecular-Biology-Enzymes-Kits--Reagents-Market-by-Application-Cloning-Epigenetics-PCR-Restriction-Digestion-Sequencing-Product-Ligase-Phosphatase-Polymerase-Protease-Restriction-Endonuclease-Reverse-Transcriptase-Global-Forecast-to-2018.html



__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Identity is in everything and customers are looking to their providers to ensure the security of their identities, transactions and data. With the increased reliance on cloud-based services, service providers must build security and trust into their offerings, adding value to customers and improving the user experience. Making identity, security and privacy easy for customers provides a unique advantage over the competition.
CenturyLink has announced that application server solutions from GENBAND are now available as part of CenturyLink’s Networx contracts. The General Services Administration (GSA)’s Networx program includes the largest telecommunications contract vehicles ever awarded by the federal government. CenturyLink recently secured an extension through spring 2020 of its offerings available to federal government agencies via GSA’s Networx Universal and Enterprise contracts. GENBAND’s EXPERiUS™ Application...
"We've discovered that after shows 80% if leads that people get, 80% of the conversations end up on the show floor, meaning people forget about it, people forget who they talk to, people forget that there are actual business opportunities to be had here so we try to help out and keep the conversations going," explained Jeff Mesnik, Founder and President of ContentMX, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
SYS-CON Events announced today that Isomorphic Software will exhibit at DevOps Summit at 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Isomorphic Software provides the SmartClient HTML5/AJAX platform, the most advanced technology for building rich, cutting-edge enterprise web applications for desktop and mobile. SmartClient combines the productivity and performance of traditional desktop software with the simp...
"When you think about the data center today, there's constant evolution, The evolution of the data center and the needs of the consumer of technology change, and they change constantly," stated Matt Kalmenson, VP of Sales, Service and Cloud Providers at Veeam Software, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
Redis is not only the fastest database, but it is the most popular among the new wave of databases running in containers. Redis speeds up just about every data interaction between your users or operational systems. In his session at 19th Cloud Expo, Dave Nielsen, Developer Advocate, Redis Labs, will share the functions and data structures used to solve everyday use cases that are driving Redis' popularity.
I wanted to gather all of my Internet of Things (IOT) blogs into a single blog (that I could later use with my University of San Francisco (USF) Big Data “MBA” course). However as I started to pull these blogs together, I realized that my IOT discussion lacked a vision; it lacked an end point towards which an organization could drive their IOT envisioning, proof of value, app dev, data engineering and data science efforts. And I think that the IOT end point is really quite simple…
Internet of @ThingsExpo, taking place November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with the 19th International Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world and ThingsExpo Silicon Valley Call for Papers is now open.
You think you know what’s in your data. But do you? Most organizations are now aware of the business intelligence represented by their data. Data science stands to take this to a level you never thought of – literally. The techniques of data science, when used with the capabilities of Big Data technologies, can make connections you had not yet imagined, helping you discover new insights and ask new questions of your data. In his session at @ThingsExpo, Sarbjit Sarkaria, data science team lead ...
To leverage Continuous Delivery, enterprises must consider impacts that span functional silos, as well as applications that touch older, slower moving components. Managing the many dependencies can cause slowdowns. See how to achieve continuous delivery in the enterprise.
WebRTC is bringing significant change to the communications landscape that will bridge the worlds of web and telephony, making the Internet the new standard for communications. Cloud9 took the road less traveled and used WebRTC to create a downloadable enterprise-grade communications platform that is changing the communication dynamic in the financial sector. In his session at @ThingsExpo, Leo Papadopoulos, CTO of Cloud9, discussed the importance of WebRTC and how it enables companies to focus...
"My role is working with customers, helping them go through this digital transformation. I spend a lot of time talking to banks, big industries, manufacturers working through how they are integrating and transforming their IT platforms and moving them forward," explained William Morrish, General Manager Product Sales at Interoute, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
Up until last year, enterprises that were looking into cloud services usually undertook a long-term pilot with one of the large cloud providers, running test and dev workloads in the cloud. With cloud’s transition to mainstream adoption in 2015, and with enterprises migrating more and more workloads into the cloud and in between public and private environments, the single-provider approach must be revisited. In his session at 18th Cloud Expo, Yoav Mor, multi-cloud solution evangelist at Cloudy...
Aspose.Total for .NET is the most complete package of all file format APIs for .NET as offered by Aspose. It empowers developers to create, edit, render, print and convert between a wide range of popular document formats within any .NET, C#, ASP.NET and VB.NET applications. Aspose compiles all .NET APIs on a daily basis to ensure that it contains the most up to date versions of each of Aspose .NET APIs. If a new .NET API or a new version of existing APIs is released during the subscription peri...
Security, data privacy, reliability, and regulatory compliance are critical factors when evaluating whether to move business applications from in-house, client-hosted environments to a cloud platform. Quality assurance plays a vital role in ensuring that the appropriate level of risk assessment, verification, and validation takes place to ensure business continuity during the migration to a new cloud platform.